These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 38101777

  • 1. [Interferon-α mediating the functional damage of CD56dimCD57+natural killer cells in peripheral blood of systemic lupus erythematosuss].
    Zhao XG, Liu JQ, Huang HN, Lu ZM, Bai ZR, Li X, Qi JJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):975-981. PubMed ID: 38101777
    [Abstract] [Full Text] [Related]

  • 2. Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus.
    Lu Z, Tian Y, Bai Z, Liu J, Zhang Y, Qi J, Jin M, Zhu J, Li X.
    Arthritis Res Ther; 2022 Feb 16; 24(1):48. PubMed ID: 35172900
    [Abstract] [Full Text] [Related]

  • 3. Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus.
    Liu M, Liu J, Zhang X, Xiao Y, Jiang G, Huang X.
    Clin Rheumatol; 2021 Mar 16; 40(3):1103-1112. PubMed ID: 32797360
    [Abstract] [Full Text] [Related]

  • 4. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
    Henriques A, Teixeira L, Inês L, Carvalheiro T, Gonçalves A, Martinho A, Pais ML, da Silva JA, Paiva A.
    Clin Rheumatol; 2013 Jun 16; 32(6):805-13. PubMed ID: 23377197
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
    Lin SJ, Kuo ML, Hsiao HS, Lee PT, Lee WI, Chen JY, Huang JL.
    Mediators Inflamm; 2019 Jun 16; 2019():4236562. PubMed ID: 31049024
    [Abstract] [Full Text] [Related]

  • 6. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
    Chalan P, Bijzet J, Kroesen BJ, Boots AM, Brouwer E.
    J Rheumatol; 2016 Jun 16; 43(6):1008-16. PubMed ID: 27036380
    [Abstract] [Full Text] [Related]

  • 7. Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis.
    Scrivo R, Peruzzi G, Gattamelata A, Gross CC, Carletti R, Di Gioia C, Brandt J, Priori R, Morrone S, Santoni A, Valesini G.
    Cytometry B Clin Cytom; 2018 May 16; 94(3):412-422. PubMed ID: 28834234
    [Abstract] [Full Text] [Related]

  • 8. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM, Abdel-Rahim MH, Elsayh KI, Hassanien MM, Mahran SA, Hetta HF.
    Arch Immunol Ther Exp (Warsz); 2019 Jun 16; 67(3):161-169. PubMed ID: 30944972
    [Abstract] [Full Text] [Related]

  • 9. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
    Domaica CI, Fuertes MB, Uriarte I, Girart MV, Sardañons J, Comas DI, Di Giovanni D, Gaillard MI, Bezrodnik L, Zwirner NW.
    PLoS One; 2012 Jun 16; 7(12):e51677. PubMed ID: 23240056
    [Abstract] [Full Text] [Related]

  • 10. CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.
    Vujanovic L, Chuckran C, Lin Y, Ding F, Sander CA, Santos PM, Lohr J, Mashadi-Hossein A, Warren S, White A, Huang A, Kirkwood JM, Butterfield LH.
    Front Immunol; 2019 Jun 16; 10():14. PubMed ID: 30761123
    [Abstract] [Full Text] [Related]

  • 11. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T, Seki S, Dobashi H, Koike Y, Habu Y, Ami K, Hiraide H, Sekine I.
    Immunology; 2001 Jul 16; 103(3):281-90. PubMed ID: 11454057
    [Abstract] [Full Text] [Related]

  • 12. Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy.
    Cao W, Lu H, Zhang L, Wang S, Deng W, Jiang T, Lin Y, Yang L, Bi X, Lu Y, Zhang L, Shen G, Liu R, Chang M, Wu S, Gao Y, Hao H, Xu M, Chen X, Hu L, Xie Y, Li M.
    Front Immunol; 2022 Jul 16; 13():1067362. PubMed ID: 36479104
    [Abstract] [Full Text] [Related]

  • 13. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
    Naluyima P, Eller MA, Laeyendecker O, Quinn TC, Serwadda D, Sewankambo NK, Gray RH, Michael NL, Wabwire-Mangen F, Robb ML, Sandberg JK.
    AIDS; 2014 Jun 01; 28(9):1273-8. PubMed ID: 24959961
    [Abstract] [Full Text] [Related]

  • 14. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
    Mirjačić Martinović K, Babović N, Džodić R, Jurišić V, Matković S, Konjević G.
    J Transl Med; 2015 Apr 14; 13():120. PubMed ID: 25889680
    [Abstract] [Full Text] [Related]

  • 15. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA, Demberg T, Robert-Guroff M.
    Immunology; 2011 Nov 14; 134(3):326-40. PubMed ID: 21978002
    [Abstract] [Full Text] [Related]

  • 16. CD56brightCD16- natural killer cells are shifted toward an IFN-γ-promoting phenotype with reduced regulatory capacity in osteoarthritis.
    Wang H, Zeng Y, Zhang M, Ma H, Xu B, Jiang H, Wang J, Li G.
    Hum Immunol; 2019 Oct 14; 80(10):871-877. PubMed ID: 31326139
    [Abstract] [Full Text] [Related]

  • 17. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD, Falconer K, Björkström NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK.
    J Immunol; 2009 Nov 15; 183(10):6612-8. PubMed ID: 19846870
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease.
    Shimojima Y, Kishida D, Ueno KI, Ushiyama S, Ichikawa T, Sekijima Y.
    J Rheumatol; 2019 Oct 15; 46(10):1268-1276. PubMed ID: 30770498
    [Abstract] [Full Text] [Related]

  • 19. Role of IL-24 in NK cell activation and its clinical implication in systemic lupus erythematosus.
    Tang Y, Sun X, Wang Y, Luan H, Zhang R, Hu F, Sun X, Li X, Guo J.
    Clin Rheumatol; 2021 Jul 15; 40(7):2707-2715. PubMed ID: 33534028
    [Abstract] [Full Text] [Related]

  • 20. The phenotype of CD3-CD56bright and CD3-CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity.
    Soelistyoningsih D, Susianti H, Kalim H, Handono K.
    Reumatologia; 2022 Jul 15; 60(4):258-265. PubMed ID: 36186836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.